Concepedia

Ángel Gálvez

ÁG

11

Publications

299

Citations

11

H-Index

1998

Active since

Affiliations

Advocate Lutheran General Hospital(Current)

Oncology Specialists

Thrombosis Research Institute

University of Insubria

Mahidol University

Ángel Gálvez is an author at Advocate Lutheran General Hospital specializing in medicine, oncology, and pharmacology.

ORCID

Top concepts

Publications per year

1998–2022

11

Publications

11

Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

Chadi Nabhan, Timothy M. Lestingi, Ángel Gálvez et al. · Urology · 2009 · 54 citations

, , +8

Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII

Howard A. Liebman, Juan Chediak, Kenneth I. Fink et al. · American Journal of Hematology · 2000 · 41 citations · Full text

Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

Sylvia Haas, Walter Ageno, Jeffrey I. Weitz et al. · Journal of Thrombosis and Haemostasis · 2019 · 41 citations · Full text

, , +11

Quality of life assessment for low literacy Latinos: a new multimedia program for self-administration.

Elizabeth A. Hahn, David Cellal, Deborah Dobrez et al. · PubMed · 2004 · 29 citations

, , +28

36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

Alexander G.G. Turpie, Alfredo E. Farjat, Sylvia Haas et al. · Thrombosis Research · 2022 · 26 citations · Full text

Rows per page

1–5 of 11